▎药明康德内容团队编辑
图片来源:123RF
▲CB-010的初步疗效结果(图片来源:Caribou Biosciences官网)
参考资料:
[1] ADC Therapeutics Announces Results from Pivotal Phase 2 Clinical Trial of Camidanlumab Tesirine (Cami) in Relapsed or Refractory Hodgkin Lymphoma. Retrieved June 10, 2022, from http://www.businesswire.com/news/home/20220610005073/en
[2] Wugen Presents New Preclinical Data Demonstrating Enhanced Anti-Tumor Activity of WU-NK-101 at the European Hematology Association (EHA) 2022 Hybrid Congress. Retrieved June 10, 2022, from http://www.businesswire.com/news/home/20220610005107/en
[3] Caribou Biosciences Reports Positive Additional Data from CB-010 Allogeneic CAR-T Cell Therapy Phase 1 ANTLER Trial at the European Hematology Association (EHA) 2022 Hybrid Congress. Retrieved June 10, 2022, from http://www.globenewswire.com/news-release/2022/06/10/2460243/0/en/Caribou-Biosciences-Reports-Positive-Additional-Data-from-CB-010-Allogeneic-CAR-T-Cell-Therapy-Phase-1-ANTLER-Trial-at-the-European-Hematology-Association-EHA-2022-Hybrid-Congress.html
[4] Genentech Announces Positive Data from Broad Blood Cancer Portfolio at European Hematology Association Annual Meeting. Retrieved June 10, 2022, from http://www.businesswire.com/news/home/20220609005656/en
[5] Vor Bio Successfully Demonstrates Multiplex Editing of Hematopoietic Stem Cells for Next-generation AML Treatment Presented at EHA. Retrieved June 10, 2022, from http://ir.vorbio.com/news-releases/news-release-details/vor-bio-successfully-demonstrates-multiplex-editing
[6] Janssen Presents Updated Data at EHA for Teclistamab in Patients with Relapsed or Refractory Multiple Myeloma. Retrieved June 10, 2022, from http://www.janssen.com/janssen-presents-updated-data-eha-teclistamab-patients-relapsed-or-refractory-multiple-myeloma
[7] AbbVie Presents Investigational Navitoclax Preliminary Data in JAK Inhibitor Naïve Myelofibrosis Patients. Retrieved June 10, 2022, from http://news.abbvie.com/news/press-releases/abbvie-presents-investigational-navitoclax-preliminary-data-in-jak-inhibitor-nave-myelofibrosis-patients.htm
版权说明:本文来自药明康德内容团队,欢迎个人转发至朋友圈,谢绝媒体或机构未经授权以任何形式转载至其他..。转载授权请在「药明康德」微信公众号回复“转载”,获取转载须知。
分享,点赞,在看,聚焦全球生物医药健康创新
大家好,小美今天来为大家解答唱歌的技巧与诀窍以下问题,唱歌的技巧与诀窍视频很多人还不知道,现在让我们一起来看看吧!1、姿势 正确的唱歌
大家好,小娟今天来为大家解答合伙人股权协议书风险以下问题,合伙人合同协议书法律风险很多人还不知道,现在让我们一起来看看吧!1、常见的
点击蓝字 存眷我们起原:安徽公安交警在线主办:芜湖市湾沚区人民当局办公室 承办:芜湖市湾沚区大数据中心 审核:钱梦婷、孙一沙、沈启叶
中华人民共和国粹位法(2024年4月26日第十四届全国人民代表大会常务委员会第九次会议经由)目 录第一章 总 则第二章 学位工作体系第三
文稿/教务处 编纂/郭新莹 审阅/张 岭
↑点击上方存眷,微报带你纵览澳洲资讯//媒介//收集的显现增强了人与人之间的关联,也成为了人们之间的一重屏障,有的时候基本不知道在网线的
大家好,小美今天来为大家解答悉尼是哪个国家的以下问题,悉尼是哪个国家的首都请回答很多人还不知道,现在让我们一起来看看吧!1、最佳答案
大家好,小娟今天来为大家解答快手直播号购买以下问题,快手直播很多人还不知道,现在让我们一起来看看吧!1、快手官方平台。
2、快跟海爪网
Copyright 2024 优质自媒体,让大家了解更多图文资讯!